Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn).
Guerra E, Ricci G, Carlesimo M, Varani AR, Pontesilli O, Scala E, Mezzaroma I, Pierdominici, Pandolfi F, Antinori A, De Luca A, Murri R, Ammassari A, Ortona L, Aiuti F.
Guerra E, et al. Among authors: ammassari a.
Antibiot Chemother (1971). 1996;48:147-54. doi: 10.1159/000425171.
Antibiot Chemother (1971). 1996.
PMID: 8726519
Clinical Trial.
No abstract available.